Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.98 USD | +16.02% |
|
-5.37% | +221.86% |
06-10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
05-09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- MarketScreener Editorial Features